Skip to content

Opening book details…

About this Medicine article

Bevacizumab in Treatment of High-Risk Ovarian Cancer—A Cost-Effectiveness Analysis by Chan, J. K.; Herzog, T. J.; Hu, L.; Monk, B. J.; Kiet, T.; Blansit, K.; Kapp, D. S.; Yu, X. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Chan, J. K.; Herzog, T. J.; Hu, L.; Monk, B. J.; Kiet, T.; Blansit, K.; Kapp, D. S.; Yu, X.
Publisher
Alphamed Press; AlphaMed Press Inc; Wiley (ISSN 1083-7159)
Published
2014
Field
Medicine (Health Sciences)

More by Chan, J. K.; Herzog, T. J.; Hu, L.; Monk, B. J.; Kiet, T.; Blansit, K.; Kapp, D. S.; Yu, X.

Browse all works by Chan, J. K.; Herzog, T. J.; Hu, L.; Monk, B. J.; Kiet, T.; Blansit, K.; Kapp, D. S.; Yu, X.